Trazium
Подписчиков: 0, рейтинг: 0
This article is about an antidepressant. For the antibiotic with the trade name Trazium, see ceftriaxone.
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H13ClN3O |
| Molar mass | 310.76 g·mol−1 |
Trazium (EGYT-3,615) is an antidepressant drug which was never marketed. It has psychostimulant-like effects and its actions appear to be mediated by the dopaminergic and adrenergic systems. It was formulated as a salt with ethanesulfonic acid and given the generic name trazium esilate (INN).
| |||||||||||||||||||||
| |||||||||||||||||||||
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| α1 |
|
||||
|---|---|---|---|---|---|
| α2 |
|
||||
| β |
|
||||
| D1-like |
|
||||||
|---|---|---|---|---|---|---|---|
| D2-like |
|
||||||